Cargando…

Antibiotics The Perfect Storm /

Antibiotics are truly miracle drugs. As a class, they are one of the only ones that actually cure disease as opposed to most drugs that only help relieve symptoms or control disease. Because bacteria that cause serious disease in humans are becoming more and more resistant to the antibiotics we have...

Descripción completa

Detalles Bibliográficos
Clasificación:Libro Electrónico
Autor principal: Shlaes, David M. (Autor)
Autor Corporativo: SpringerLink (Online service)
Formato: Electrónico eBook
Idioma:Inglés
Publicado: Dordrecht : Springer Netherlands : Imprint: Springer, 2010.
Edición:1st ed. 2010.
Temas:
Acceso en línea:Texto Completo

MARC

LEADER 00000nam a22000005i 4500
001 978-90-481-9057-7
003 DE-He213
005 20220117223930.0
007 cr nn 008mamaa
008 100907s2010 ne | s |||| 0|eng d
020 |a 9789048190577  |9 978-90-481-9057-7 
024 7 |a 10.1007/978-90-481-9057-7  |2 doi 
050 4 |a R850.A1-854 
050 4 |a QH315-320 
072 7 |a MBGR  |2 bicssc 
072 7 |a MED000000  |2 bisacsh 
072 7 |a MBGR  |2 thema 
082 0 4 |a 610.72  |2 23 
100 1 |a Shlaes, David M.  |e author.  |4 aut  |4 http://id.loc.gov/vocabulary/relators/aut 
245 1 0 |a Antibiotics  |h [electronic resource] :  |b The Perfect Storm /  |c by David M. Shlaes. 
250 |a 1st ed. 2010. 
264 1 |a Dordrecht :  |b Springer Netherlands :  |b Imprint: Springer,  |c 2010. 
300 |a VIII, 106 p.  |b online resource. 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
347 |a text file  |b PDF  |2 rda 
505 0 |a 1 The Perfect Storm -- 2 The Miracle -- 3 Resistance - The miracle is fading -- 4 The FDA - We need them, but they have become part of the problem -- 5 Europe -- 6 The Pharmaceutical Industry - after a glorious history, the industry is now struggling on all fronts -- 7 Modest Proposals -- 8 Conclusions. 
520 |a Antibiotics are truly miracle drugs. As a class, they are one of the only ones that actually cure disease as opposed to most drugs that only help relieve symptoms or control disease. Because bacteria that cause serious disease in humans are becoming more and more resistant to the antibiotics we have today, and because they will ultimately become resistant to any antibiotic that we use for treatment or for anything else (like crops, animals, etc.), we need a steady supply of new antibiotics active against the resistant bacteria that arise. But the antibiotics marketplace is no longer attractive for large pharmaceutical companies, the costs of development are skyrocketing because of ever more stringent requirements by the regulatory agencies and finding new antibiotics active against resistant strains is getting harder and harder. These forces are all combining to deny us these miracle drugs when we need them the most. I provide a number of possible paths to shelter from this perfect storm. 
650 0 |a Medicine-Research. 
650 0 |a Biology-Research. 
650 0 |a Immunology. 
650 0 |a Medical microbiology. 
650 0 |a Pharmacology. 
650 0 |a Biotechnology. 
650 0 |a Pharmacy. 
650 1 4 |a Biomedical Research. 
650 2 4 |a Immunology. 
650 2 4 |a Medical Microbiology. 
650 2 4 |a Pharmacology. 
650 2 4 |a Biotechnology. 
650 2 4 |a Pharmacy. 
710 2 |a SpringerLink (Online service) 
773 0 |t Springer Nature eBook 
776 0 8 |i Printed edition:  |z 9789048190560 
776 0 8 |i Printed edition:  |z 9789400795327 
776 0 8 |i Printed edition:  |z 9789048190584 
856 4 0 |u https://doi.uam.elogim.com/10.1007/978-90-481-9057-7  |z Texto Completo 
912 |a ZDB-2-SBL 
912 |a ZDB-2-SXB 
950 |a Biomedical and Life Sciences (SpringerNature-11642) 
950 |a Biomedical and Life Sciences (R0) (SpringerNature-43708)